Your browser doesn't support javascript.
loading
Inhibition of 11ß-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study.
Yadav, Yogesh; Dunagan, Kelly; Khot, Rachita; Venkatesh, Sudhakar K; Port, John; Galderisi, Alfonso; Cobelli, Claudio; Wegner, Craig; Basu, Ananda; Carter, Rickey; Basu, Rita.
Affiliation
  • Yadav Y; Division of Endocrinology, University of Virginia, Charlottesville, Virginia, USA.
  • Dunagan K; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Khot R; Division of Body Imaging, Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia, USA.
  • Venkatesh SK; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Port J; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Galderisi A; Department of Woman and Child's health, University of Padova, Padova, Veneto, Italy.
  • Cobelli C; Department of Woman and Child's health, University of Padova, Padova, Veneto, Italy.
  • Wegner C; Retired from Emerging & Open Innovations Unit, IMED Biotech Unit, AstraZeneca, USA.
  • Basu A; Division of Endocrinology, University of Virginia, Charlottesville, Virginia, USA.
  • Carter R; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida, USA.
  • Basu R; Division of Endocrinology, University of Virginia, Charlottesville, Virginia, USA.
Diabetes Obes Metab ; 24(5): 881-890, 2022 05.
Article in En | MEDLINE | ID: mdl-35014156

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Non-alcoholic Fatty Liver Disease Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Non-alcoholic Fatty Liver Disease Type of study: Clinical_trials Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2022 Type: Article Affiliation country: United States